EDGE MEDICAL-B (02675) surged 38.30% during the intraday session on its Hong Kong Stock Exchange debut, driven by overwhelming investor demand. The stock opened at HK$59 per share, significantly higher than its IPO price of HK$43.24.
The company's global offering was oversubscribed by 1091.94 times in the Hong Kong public offering and 25.18 times in the international offering, raising HK$1.12 billion in net proceeds. Cornerstone investors, including Abu Dhabi Investment Authority and UBS Asset Management, participated in the offering, reflecting strong institutional confidence in the medical technology firm.